Onivyde 43 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FJF80
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,128
Award facts
- Contract value 100% obligated
- $7,127.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,127.56 to AmerisourceBergen Drug Corp for the supply of Onivyde 43 mg/10 mL vials. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA Medical Supply Chain. The company's extensive portfolio includes specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for Onivyde, a specialized oncology medication, exemplifies the company's role in supplying critical pharmaceutical commodities through DLA's competitive procurement processes.
Quick answers
Who was awarded contract SPE2DB25FJF80?
SPE2DB25FJF80 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FJF80 worth?
The government has obligated $7,128 on SPE2DB25FJF80.
Is contract SPE2DB25FJF80 an order under another contract?
Yes. SPE2DB25FJF80 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJF80 competed?
The extent of competition for SPE2DB25FJF80 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award